Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 6,526–6,550 of 27,380 studies, newest first · page 262 of 1096.

May 2024 25

  1. 2024-05-31

    Aducanumab: A look two years after its approval

    ✓ Peer-reviewed Treatments Biomedica : revista del Instituto Nacional de Salud

    Key finding: Alzheimer’s disease is the leading cause of dementia worldwide and a critical public health problem. +4 more findings

  2. 2024-05-31

    Incidence of Traumatic Brain Injury in a Longitudinal Cohort of Older Adults

    ✓ Peer-reviewed Risk factors JAMA Network Open

    Key finding: Among 9239 eligible respondents, 5258 (57.7%) were female and 1210 (9.1%) were Black, 574 (4.7%) were Hispanic, and 7297 (84.4%) were White. +4 more findings

  3. 2024-05-31

    [Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease]

    ✓ Peer-reviewed Tau biomarkers Lakartidningen

    Key finding: Plasma levels of amyloid β, specifically the Aβ42/40 ratio, are reduced in Alzheimer's disease (AD) and show concordance with brain amyloidosis assessed by PET, but the overlap with normal elderly may be too large for reliable use in clinical applications. +3 more findings

  4. 2024-05-30

    Affiliate Stigma among family caregivers of individuals with dementia in China: a cross-sectional study

    ✓ Peer-reviewed Caregiving Frontiers in public health

    Key finding: The mean score for affiliate stigma of dementia family caregivers was 48.09 ± 16.38 (range: 22-86). +3 more findings

  5. 2024-05-30

    Causal association between particulate matter 2.5 and Alzheimer's disease: a Mendelian randomization study

    ✓ Peer-reviewed Risk factors Frontiers in public health

    Key finding: Our MR analysis identified a notable association between genetically predicted PM2.5 (PM with a diameter of 2.5 μm or less) exposure and an elevated risk of AD (odds ratio, 2.160; 95% confidence interval, 1.481 to 3.149; p < 0.001). +4 more findings

  6. 2024-05-30

    Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-ADmini randomized controlled trial

    ✓ Peer-reviewed Prevention trials Alzheimer's research & therapy

    Key finding: Primary outcome was feasibility of the multimodal intervention, evaluated by recruitment rate during a 6-month recruitment phase, overall adherence in each intervention arm, and 6-month retention rate. +4 more findings

  7. 2024-05-30

    Medicare Advantage enrollment and outcomes of post-acute nursing home care among patients with dementia

    ✓ Peer-reviewed Health systems and care delivery Health Affairs Scholar

    Key finding: After adjusting for patient-level characteristics and county fixed effects, we found that MA enrollment was not associated with days spent at home, nursing home days, likelihood of becoming a long-stay resident, hospital days, hospital readmission, or 1-year mortality. +3 more findings

  8. 2024-05-29

    Geographic Variation of Antidementia and Antipsychotic Medication Use Among US Nursing Home Residents With Dementia

    ✓ Peer-reviewed Risk factors Medical Care

    Key finding: memantine, cholinesterase inhibitor (ChEI), antipsychotic use] estimated adjusted odds ratios (aOR) and 95% CIs for resident, facility, and HRR characteristics. +4 more findings

  9. 2024-05-29

    A multimodal machine learning model for predicting dementia conversion in Alzheimer’s disease

    ✓ Peer-reviewed Health systems and care delivery Scientific Reports

    Key finding: As a result of testing the robustness of the model, the GBM model was the most stable, and in modality combination, model performance was further improved in the absence of T2-FLAIR image features.

  10. 2024-05-29

    Cholinesterase inhibitors and memantine are associated with a reduced mortality in nursing home residents with dementia: a longitudinal observational study

    ✓ Peer-reviewed Treatments Alzheimer's Research & Therapy

    Key finding: The use of conventional anti-dementia drugs is associated with a lower mortality in nursing home residents with dementia and should be widely used in this population. +3 more findings

  11. 2024-05-28

    Environmental pollution and extreme weather conditions: insights into the effect on mental health

    ✓ Peer-reviewed Risk factors Frontiers in psychiatry

    Key finding: However, the knowledge about possible psychiatric disorders associated with these exposures is currently not well disseminated. +3 more findings

  12. 2024-05-28

    Physical exercise, cognition, and brain health in aging

    ✓ Peer-reviewed Prevention trials Trends in neurosciences

    Key finding: We conclude by highlighting goals for future studies, including addressing unexplored neurobiological mechanisms and the inclusion of under-represented populations.

  13. 2024-05-28

    An immersive virtual reality shopping task detects declines in instrumental activities of daily living in individuals with Parkinson's disease

    ✓ Peer-reviewed Risk factors Parkinsonism & Related Disorders

    Key finding: There were no between-group differences in traditional performance measures of motor, cognitive, or IADL function. +4 more findings

  14. 2024-05-26

    The Association of Ancillary Diagnostic Tests With Outcome in Dementia

    ✓ Peer-reviewed Health systems and care delivery Journal of the American Medical Directors Association

    Key finding: Patients who underwent CSF testing or PET/SPECT had higher mean total health care costs as compared to controls (CSF €248, 95% CI 64-433; PET/SPECT: €315, 95% CI 179-451). +2 more findings

  15. 2024-05-24

    Biobank-wide association scan identifies risk factors for late-onset Alzheimer's disease and endophenotypes

    ✓ Peer-reviewed Genetics eLife

    Key finding: Compared to traditional approaches, BADGERS uses GWAS summary statistics as input and does not require multiple traits to be measured in the same cohort. +4 more findings

  16. 2024-05-24

    Neuronal glutathione depletion elevates the Aβ42/Aβ40 ratio and tau aggregation in Alzheimer's disease mice

    ✓ Peer-reviewed Biomarkers FEBS letters

    Key finding: These findings suggest that the decline in glutathione levels, due to aging or AD pathology, may contribute to the progression of AD.

  17. 2024-05-24

    A Data-Driven Approach to Defining Risk-Adjusted Coding Specificity Metrics for a Large U.S. Dementia Patient Cohort

    ✓ Peer-reviewed Health systems and care delivery Healthcare (Basel, Switzerland)

    Key finding: Inadequate coding specificity can have significant consequences at administrative and patient levels. +2 more findings

  18. 2024-05-24

    Alzheimer's disease and its treatment-yesterday, today, and tomorrow

    ✓ Peer-reviewed Drug development Frontiers in pharmacology

    Key finding: AD is a multi-factorial neurodegenerative disorder with familial, life style and comorbidity influences impacting a global population of more than 47 million with a projected escalation by 2050 to exceed 130 million. +3 more findings

  19. 2024-05-23
  20. 2024-05-23

    Hearing Loss and Cognitive Decline in the Aging Population: Emerging Perspectives in Audiology

    ✓ Peer-reviewed Risk factors Audiology research

    Key finding: Highlighting the evolving significance of audiologists in the dual management of cognitive health and hearing impairments, the author focuses on their role in identifying early signs of cognitive impairment and evaluates various cognitive screening tools used in this context. +4 more findings

  21. 2024-05-23
  22. 2024-05-23

    Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: Aβ-PET was abnormal in 81 participants from J-TRC and 71 participants from BioFINDER. +1 more finding

  23. 2024-05-23

    Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease

    ✓ Peer-reviewed Tau biomarkers Annals of neurology

    Key finding: Irisin, released by muscles during exercise, was recently identified as a neuroprotective factor in mouse models of Alzheimer disease (AD). +3 more findings

  24. 2024-05-23

    Distinct roles of TREM2 in central nervous system cancers and peripheral cancers

    ✓ Peer-reviewed TREM2 and immune genetics Cancer cell

    Key finding: Whether myeloid cell-directed therapeutic targets identified in peripheral non-CNS cancers are applicable to GBM requires further study. +3 more findings

  25. 2024-05-22

    Drug repurposing for neurodegenerative diseases

    ✓ Peer-reviewed Drug development Progress in molecular biology and translational science

    Key finding: Neurodegenerative diseases (NDDs) are neuronal problems that include the brain and spinal cord and result in loss of sensory and motor dysfunction. +2 more findings

Browse the library by subject, with the full score breakdown →